DURHAM, N.C., Sept. 18 /PRNewswire/ -- bioMerieux, a global leader in the field of in vitro diagnostics, has acquired Bacterial Barcodes, Inc. (BBCI), a molecular biotechnology company, based in Athens, Georgia. BBCI developed and markets DiversiLab(TM), a patented system dedicated to the field of automated microbial genotyping, offering solutions to track hospital-acquired infections (HAI) and for environmental control for product safety.
